Loading
Latest filing published 22 Mar 2022 for Adamis Pharmaceuticals Corp, €6,412.
David J. Marguglio is a declared insider of Adamis Pharmaceuticals Corp (board member), with filings sourced from SEC (Form 4). The record holds 22 filings, for trades running from 14 April 2016 to 18 March 2022.
No open-market purchase appears, only 20 sales worth €396k. Besides market trades, the filings include 1 share grant and 1 option exercise. So far in 2022, the count stands at no purchases and 1 sale.
The newest entry dates from 22 March 2022: an open-market sale of €6,412, in Adamis Pharmaceuticals Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations